Autonomix Medical Reports Positive Outcomes In Initial Phase Of First-In-Human Proof-Of-Concept Trial In Pancreatic Cancer Pain And Initiates Market Expansion Study For Visceral Cancer Pain
April 30 (Reuters) - Autonomix Medical Inc AMIX.O:
AUTONOMIX MEDICAL, INC. REPORTS POSITIVE OUTCOMES IN INITIAL PHASE OF FIRST-IN-HUMAN PROOF-OF-CONCEPT TRIAL IN PANCREATIC CANCER PAIN AND INITIATES MARKET EXPANSION STUDY FOR VISCERAL CANCER PAIN
AUTONOMIX MEDICAL INC - NO DEVICE OR PROCEDURE-RELATED SERIOUS ADVERSE EVENTS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.